EFFICACY AND SAFETY EVALUATION OF EN3348 (MYCOBACTERIAL CELL WALL-DNA COMPLEX [MCC]) AS COMPARED WITH MITOMYCIN C IN THE INTRAVESICAL TREATMENT OF SUBJECTS WITH BCG RECURRENT/REFRACTORY NON-MUSCLE INVASIVE BLADDER CANCER: